CELLULARWOUND Trademark

Trademark Overview


On Monday, August 7, 2023, a trademark application was filed for CELLULARWOUND with the United States Patent and Trademark Office. The USPTO has given the CELLULARWOUND trademark a serial number of 98120013. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Monday, July 8, 2024. This trademark is owned by RegenLab USA LLC. The CELLULARWOUND trademark is filed in the Medical Instrument Products category with the following description:

Medical apparatus and instruments for use in mesotherapy, esthetic, and pain management procedures; surgical and medical apparatus and instruments for use in dental, orthopedic, cosmetic, esthetic, and ophthalmological surgery; surgical and medical apparatus and instruments for use in cardiovascular, esthetic, cardiac, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; surgical instruments, namely, glass tubes for separating biological tissues; medical and surgical apparatus and instruments for use in general surgery; Surgical, medical and veterinary apparatus and instruments, including apparatus and instruments for autologous blood treatment, blood collection apparatus and instruments, apparatus and instruments for blood separation, apparatus and instruments for bone marrow separation, apparatus and instruments for centrifugation of blood, apparatus and instruments for fi...
cellularwound

General Information


Serial Number98120013
Word MarkCELLULARWOUND
Filing DateMonday, August 7, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateMonday, July 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkCELLULAR WOUND
Goods and ServicesMedical apparatus and instruments for use in mesotherapy, esthetic, and pain management procedures; surgical and medical apparatus and instruments for use in dental, orthopedic, cosmetic, esthetic, and ophthalmological surgery; surgical and medical apparatus and instruments for use in cardiovascular, esthetic, cardiac, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; surgical instruments, namely, glass tubes for separating biological tissues; medical and surgical apparatus and instruments for use in general surgery; Surgical, medical and veterinary apparatus and instruments, including apparatus and instruments for autologous blood treatment, blood collection apparatus and instruments, apparatus and instruments for blood separation, apparatus and instruments for bone marrow separation, apparatus and instruments for centrifugation of blood, apparatus and instruments for filtering blood, and coagulation instruments; Surgical, medical and veterinary apparatus and instruments for the production of platelet rich plasma membranes, bone marrow concentrate, and platelet rich plasma in combination with hyaluronic acid

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, September 5, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegenLab USA LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressJersey City, NJ 07302

Trademark Events


Event DateEvent Description
Thursday, August 10, 2023NEW APPLICATION ENTERED
Wednesday, December 20, 2023ASSIGNED TO EXAMINER
Tuesday, September 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 2, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 2, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 2, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 8, 2024FINAL REFUSAL E-MAILED
Monday, July 8, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, July 8, 2024FINAL REFUSAL WRITTEN